Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) *

Abstract: We define delayed graft function (DGF) as the need for dialysis during the first post‐transplant week. We analyzed 5272 transplants, of which 2486 were of living donor (LD) and 2786 were of cadaver donor (CD) origin. Twelve per cent (620/5272) of all patients developed DGF. Donor specific rates were 5.6% for LD and 19.1% for CD patients. Factors predictive of DGF in CD patients were: African‐American race (25%), prolonged cold ischemia (24%), absence of T‐cell induction antibody therapy and absence of HLA‐DR matching. The relative risk (RR) for graft failure due to DGF was 6.02 (p < 0.001) in LD patients and 2.58 (p < 0.001) for CD recipients. Two‐year graft survival (GS) in LD patients without DGF was 89.6%, compared to 41.6% for those with DGF (p < 0.001); in CD patients it was 80.2% and 49.5%, respectively (p < 0.001). Censoring for primary non‐function, GS for LD patients with a functioning graft at 30 d post‐transplant and no DGF was 91.5%, compared to 70.1% for those with DGF (p < 0.001); GS for CD patients was 83.8% and 68.7%, respectively (p < 0.001). However, when patients whose grafts had failed during the first year were censored no differences in GS were noted between patients with and without DGF for either LD or CD recipients. To determine whether DGF acts as an independent risk factor for graft failure, patients were segregated into four groups: rejection with DGF; rejection without DGF; DGF without rejection; and no DGF, no rejection. When these groups were compared DGF emerged as an independent risk factor for graft failure. This large study reviewing pediatric renal transplantation over 10 yr clearly delineates the role of DGF as a major risk factor for graft failure.

[1]  R. Strieter,et al.  In vitro and in vivo interleukin-8 production in human renal cortical epithelia. , 1992, Kidney international.

[2]  S. Freedland,et al.  Economic impact of delayed graft function and suboptimal kidneys , 1999 .

[3]  F. Cosio,et al.  Impact of acute rejection and early allograft function on renal allograft survival. , 1997, Transplantation.

[4]  A. Matas,et al.  Fixed‐Rate Reimbursement Fails to Cover Costs for Patients with Delayed Graft Function , 1991, Pharmacotherapy.

[5]  D. Sutherland,et al.  THE EFFECTS OF DELAYED FUNCTION OF RECIPIENTS OF CADAVER RENAL ALLOGRAFTS: A STUDY OF 158 PATIENTS RANDOMIZED TO CYCLOSPORINE OR ALG‐AZATHIOPRINE , 1986, Transplantation.

[6]  W K Vaughn,et al.  THE DETRIMENTAL EFFECTS OF DELAYED GRAFT FUNCTION IN CADAVER DONOR RENAL TRANSPLANTATION , 1984, Transplantation.

[7]  B. Brenner,et al.  Nephron underdosing: a programmed cause of chronic renal allograft failure. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  G. Danovitch,et al.  The high cost of delayed graft function in cadaveric renal transplantation. , 1991, Transplantation.

[9]  C. Ferran,et al.  Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]. , 1989, The New England journal of medicine.

[10]  W. Bennett,et al.  Influence of acute tubular necrosis on first cadaver kidney transplant function. , 1984, The Journal of urology.

[11]  J. Najarian,et al.  Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression. , 1984, Transplantation Proceedings.

[12]  T. Buselmeier,et al.  Postoperative Chronic Renal Failure: A New Syndrome , 1975, Annals of surgery.

[13]  R. Wolfe,et al.  Delayed graft function: risk factors and implications for renal allograft survival. , 1997, Transplantation.

[14]  A. Matas,et al.  Economic impact of delayed graft function. , 1991, Transplantation proceedings.

[15]  S. Kunkel,et al.  Epithelial-derived neutrophil-activating factor-78 production in human renal tubule epithelial cells and in renal allograft rejection. , 1995, Transplantation.

[16]  R. Thurman,et al.  Prevention of cyclosporine-induced nephrotoxicity with dietary glycine. , 1997, Transplantation.

[17]  J. Najarian,et al.  Etiology and prognosis in acute post-transplant renal failure. , 1976, The American journal of medicine.

[18]  V. Farewell,et al.  EARLY FUNCTION AS THE PRINCIPAL CORRELATE OF GRAFT SURVIVAL , 1988 .

[19]  J. Najarian,et al.  Acute tubular necrosis after renal transplantation. , 1980, Transplantation.

[20]  D. Stablein,et al.  Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study. , 1996, Transplantation.

[21]  S. Alexander,et al.  Analysis of rejection outcomes and implications--a report of the North American Pediatric Renal Transplant Cooperative Study. , 1995, Transplantation.

[22]  D. Dunn,et al.  Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good graft function at 1 year after transplantation. , 1996, Transplantation.

[23]  E. Sullivan,et al.  Factors that impact on the outcome of second renal transplants in children. , 1996, Transplantation.